GlyProVac ApS

APSActive

CVR 39724758Rørhatten 4, 5220 Odense SØManufacture of pharmaceutical preparations· NACE 2120Est. 2018 · 7 years old7 employees

Overview Financials People & ownership Related companies

GlyProVac ApS is a Danish APS based in Odense SØ, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2018, the company has 7 employees and reported revenue of DKK -2,1M in its latest annual filing.

Revenue 2025

DKK -2,1M

+269% vs 2024

EBITDA margin

276.6%

-70% vs 2024

Net profit 2025

DKK -5,2M

-71% vs 2024

Key ratios

See full ratios →

-17.9%

This company

20212025

8.6×

This company

20212025

-111.5%

This company

20212025

EBITDA — year on year

DKK millions

Key figures

Annual report 2025

Revenue	DKK -2,1M	+269%
EBITDA	DKK -5,9M	-70%
Net profit	DKK -5,2M	-71%
Total assets	DKK 4,6M	+6%
Equity	DKK -832K	-27%
Employees	7	—

Contact

Address

Rørhatten 4, 5220 Odense SØ

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the CVR number of GlyProVac ApS?

GlyProVac ApS is registered with CVR / Virk under CVR 39724758.

What is the revenue of GlyProVac ApS?

GlyProVac ApS reported revenue of DKK -2,1M in 2025.

How many employees does GlyProVac ApS have?

GlyProVac ApS employs 7 people as of the latest annual report.

Who is the CEO of GlyProVac ApS?

Anders Boysen is the CEO of GlyProVac ApS.

Who is the chairman of GlyProVac ApS?

Ann Zahle Andersen chairs the board of GlyProVac ApS, in role since 2026.

Where is GlyProVac ApS headquartered?

GlyProVac ApS's registered address is Rørhatten 4.

GlyProVac ApS

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on GlyProVac ApS

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on GlyProVac ApS